Business
XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote "For" the Share Consolidation
Your vote is important –  Vote well in advance of the proxy voting deadline: March ...
About this update from Xortx Therapeutics, Inc.
[{"type":"text","content":"XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation\nYour vote is important – Vote well in advance of the proxy voting deadline: March 20, 2026XORTX’s board of directors unanimously recommends that Shareholders vote FOR all resolutionsShareholder questions or need voting assistance? Please contact Laurel Hill Advisory Group by email at [email protected], or by texting “INFO” to, or calling, 1-877-452-7184 (North American toll-free) or 1-416-304-0211 (outside North America). CALGARY, Alberta, March 13, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (\"XORTX\" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, is pleased to announce that independent proxy advisory firms, including Institutional Shareholder Services (“ISS”) have recommended shareholders vote “FOR” on the share consolidation at the upcoming shareholder meeting scheduled for March 24, 2026. Independent Third-Party Proxy Advisory Recommendations In relation to the Share Consolidation, ISS recommended voting FOR this resolution stating: “…the stock consolidation should have no direct impact on shareholder value and could enhance the long-term growth prospects of the Company by broadening its financing alternatives.” ISS is a leading independent proxy voting and corporate governance advisory firm whose shareholder voting recommendations and analysis are subscribed to, and are relied upon, by many pension funds, investment managers, mutual funds and other institutional shareholders. Dr. Allen Davidoff, CEO and XORTX, stated, “We are pleased to receive the news that an independent third-party proxy advisory firm, ISS, has recommended shareholders vote FOR all of the proposed resolutions. This endorsement truly underscores the strength of our proposals and affirms their alignment with shareholder interests. We appreciate the support and confidence expressed by these respected advisory firms.” Shareholders Encouraged to Vote Ahead of the Proxy Deadline The Board of Directors of XORTX recommends that Shareholders vote FOR ALL resol...